Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.
about
Getting to Zero: Tuberculosis Elimination in CaliforniaAttitudes about tuberculosis prevention in the elimination phase: a survey among physicians in GermanyDiscordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.Tuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers.Serial QuantiFERON-TB Gold In-Tube assay and tuberculin skin test to diagnose latent tuberculosis in household Mexican contacts: conversion and reversion rates and associated factors using conventional and borderline zone definitions.The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission DynamicsPoor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country.Ocular Tuberculosis--A Clinical ConundrumUsing IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.Preventing the Transmission of Tuberculosis in Health Care Settings: Administrative Control.Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.Tuberculosis in healthcare workers - a narrative review from a German perspectiveIFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers.Update in tuberculosis and nontuberculous mycobacterial infections 2013.Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.Reactivation tuberculosis: role of surveillance.Detecting New Mycobacterium tuberculosis Infection. Time for a More Nuanced Interpretation of QuantiFERON Conversions.Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.T-SPOT.TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.QuantiFERON-TB Gold in-tube testing for tuberculosis in healthcare professionals.Cumulative Faults with Serial Testing for Latent Tuberculosis in Low-Risk Populations.Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette-Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study.Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results.Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.Tuberculin skin test conversions and occupational exposure risk in US healthcare workers.Occupational Screening for Tuberculosis. A Testing Time for Interferon-γ Release Assays
P2860
Q26746155-C92D4B8E-DA09-417C-B628-10738372ABCAQ28397652-896614EA-740A-4DEF-AEE8-7C8598DCEA07Q33599396-D3543050-B186-43AB-BE6F-DA365FBBF759Q33702764-93E36D5E-9B33-4845-B54A-120C593F4524Q33792760-F9A9B3B3-7A72-45EE-A79D-1CB5FD620260Q33824247-37682408-D519-4EF4-A663-A78DE3FEA2B3Q33890563-984832C7-5055-4976-BD8F-2FF6D42D2F51Q34776030-174F2105-DE4C-427C-BB9F-43A3E157990EQ34975855-139B956D-B791-4BD5-91FC-082AFEE1DCF6Q35261953-5311E45C-8950-406D-A4B0-73BBB218DA71Q35783572-F00B3A5F-4D34-41D6-BCEE-95D9F09DDE46Q36307759-3DB9EEA4-4F76-411E-ADAE-F06C27DB9632Q36599330-DF9329C2-1E51-45E9-8CDC-0471583EB584Q36981001-58B07ABE-BE70-48EF-9E03-9DF041F32067Q37544916-B7E7F276-9F9D-45D2-94F5-70469D31F67CQ37599991-568BCB44-F238-4C56-B6E1-88372ECAECC0Q37649784-EA547E5E-26D5-452A-AB04-03DE5E6312DDQ37699705-2CF170D7-2B9E-42DA-BAF5-D593E858AD6CQ38180469-35C3FCB9-041B-4961-9F8C-26606A2E3621Q38204777-B88B6623-4124-49BF-81F8-D7C15A03EE37Q38404818-5FB26C89-CA42-49E9-9D0E-27A35FDAE99FQ38670287-BA69F1C6-AA9D-4080-A300-7304E0E9B192Q38797602-1E0FA738-F7F8-4534-9BA9-0F80AE8CD065Q40099727-A738FE95-EC2E-4B3D-BE68-AC86F3BDC076Q40596209-EAF4C182-609A-4186-B5D6-AC1BD3712D29Q40897243-8DDDDFCD-970C-4B9C-BAD0-08AE7995C128Q41436229-FA04AD43-DEAE-4505-8817-02447BD9354CQ42205033-E1BC239A-D2ED-4375-A677-35E4E63FF890Q43603731-16C5C94F-E185-40B7-87CB-9F7548AD5047Q47660164-3D7076C0-3DE9-4719-A795-B17D3DE2D967Q48066031-61A00DDE-E1C6-44D2-A683-0516F7162DFAQ48119401-A8EC73E3-5A65-47AF-B95D-6FE3FFFDC9B1Q50064979-A461A8A2-3121-4031-B4BE-FFDDE7933F41Q59200599-38BD0573-3C02-4883-84AD-0E7DBB247BC5
P2860
Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@en
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@nl
type
label
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@en
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@nl
prefLabel
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@en
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@nl
P2093
P2860
P1476
Challenges with QuantiFERON-TB ...... ng of U.S. healthcare workers.
@en
P2093
Gary Welland
Julie Parsonnet
Madeline L Slater
Niaz Banaei
P2860
P304
P356
10.1164/RCCM.201305-0831OC
P407
P50
P577
2013-10-01T00:00:00Z